Positron Emission Tomography Imaging Analysis of G2A As a Negative Modifier of Lymphoid Leukemogenesis Initiated by the BCR-ABL Oncogene
Overview
Affiliations
G2A is a lymphocyte-expressed G protein-coupled receptor whose genetic ablation results in the development of autoimmunity. Using HSV-TK reporter gene directed positron emission tomography (PET), we demonstrate that prior to any indication of the onset of illness, mice transplanted with BCR-ABL transduced G2A-deficient bone marrow harbor expanded populations of leukemic cells compared to recipients of wild-type bone marrow. The target cell type and anatomical locations of leukemia development are indistinguishable in animals transplanted with G2A+/+ or G2A-/- cells. Shorter disease latency in the G2A-deficient background is associated with an increased rate of cellular expansion. PET can be successfully applied to the temporal and spatial analysis of Bcr-Abl driven leukemic progression and should have utility for the study of other leukemias and lymphomas.
Proton-sensing ion channels, GPCRs and calcium signaling regulated by them: implications for cancer.
Ji R, Chang L, An C, Zhang J Front Cell Dev Biol. 2024; 12:1326231.
PMID: 38505262 PMC: 10949864. DOI: 10.3389/fcell.2024.1326231.
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy.
Prabhu V, Morrow S, Kawakibi A, Zhou L, Ralff M, Ray J Neoplasia. 2020; 22(12):725-744.
PMID: 33142238 PMC: 7588802. DOI: 10.1016/j.neo.2020.09.005.
Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?.
Cosin-Roger J, Ortiz-Masia D, Barrachina M, Calatayud S Cells. 2020; 9(11).
PMID: 33113952 PMC: 7690732. DOI: 10.3390/cells9112345.
The role of G protein-coupled receptors in lymphoid malignancies.
Nugent A, Proia R Cell Signal. 2017; 39:95-107.
PMID: 28802842 PMC: 5600616. DOI: 10.1016/j.cellsig.2017.08.002.
Bond J, Domaschenz R, Roman-Trufero M, Sabbattini P, Ferreiros-Vidal I, Gerrard G Oncotarget. 2016; 7(40):65923-65936.
PMID: 27588474 PMC: 5323203. DOI: 10.18632/oncotarget.11688.